Prime Therapeutics: Processing Update for Generic Adderall XR® for Covered Persons of Blue Cross Blue and Shield of Alabama

Effective: 5/1/2015

Author: Angie Shirley/Tuesday, April 14, 2015/Categories: APCI Choice

Effective May 1, 2015, generic Adderall XR® (Amphetamine-Methamphetamine SR) will not be covered by Blue Cross and Blue Shield of Alabama until multiple manufacturers become available or the price decreases. The innovator product Adderall XR® will remain on the Blue Cross formulary. Coverage of Adderall XR® will be dependent on the member’s benefit.

Action Required

If Participating Pharmacies receive a prescription for Amphetamine-Dextroamphetamine SR for Covered Persons of Blue Cross, they will need to submit brand name Adderall XR® in order to receive a paid claim. If a prescription for Amphetamine-Dextroamphetamine SR is submitted instead of brand name Adderall XR®, the claim will reject at point of sale (POS) with the following reject message:

  • NCPDP Reject Code 70: “Prod/Service Not Covered”
  • Secondary Message: “AMPHETAMINE ER NOT COVERED, USE ADDERALLXR”

For questions regarding coverage of Adderall XR® or the new product, please refer Covered Persons to the Customer Service number on the back of their Blue Cross ID card.

If you have any questions regarding claims processing, please call the Prime Contact Center at 800.821.4795.

Comments are only visible to subscribers.